Edward J Lipinsky, MD in Islandia, NY - Otolaryngology

Edward J Lipinsky, MD is a Otolaryngology physician based in Islandia, New York. Edward J Lipinsky is licensed to practice in New York (license number 126333) and his current practice location is 2929 Expressway Dr N, Islandia, New York. He can be reached at his office (for appointments etc.) via phone at (631) 665-2430.

NPI number for Edward J Lipinsky is 1306932603 and his current mailing address is 560 White Plains Rd - Enta, Suite 500, Tarrytown, New York. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1306932603.

Contact Information

	Edward J Lipinsky, MD
	2929 Expressway Dr N, Islandia, NY 11749-5306
	(631) 665-2430
	(631) 665-2342

Physician's Profile

Full Name	Edward J Lipinsky
Gender	Male
Speciality	Otolaryngology
Location	2929 Expressway Dr N, Islandia, New York
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1306932603
Provider Enumeration Date: 10/05/2006
Last Update Date: 02/02/2018

Medical Identifiers

Medical identifiers for Edward J Lipinsky such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1306932603	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207Y00000X	Otolaryngology	126333 (New York)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Edward J Lipinsky is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Edward J Lipinsky, MD 560 White Plains Rd - Enta, Suite 500, Tarrytown, NY 10591-5112 Ph: (914) 984-2534	Edward J Lipinsky, MD 2929 Expressway Dr N, Islandia, NY 11749-5306 Ph: (631) 665-2430

News Archive

Scientists introduce combination approach to fight cancer

For efficient cancer therapy with few side effects, the active drug should selectively attain high concentration in the tumor. In the journal Angewandte Chemie, scientists have introduced a new approach, in which two synergistic drug components are combined into a dimer.

Health law revision suggestions pour in from lawmakers, groups

Kaiser Health News reports that vulnerable Democrats are looking for alternatives to the health law's mandate that nearly all Americans carry health insurance. "Under political pressure as a result of the new health law, Sen. Ben Nelson, D-Neb., has asked the Government Accountability Office to study alternatives to the controversial mandate requiring most Americans to obtain coverage." Because Nelson is from a typically "red" state, Republicans have targeted him as one Democrat willing to play ball on scaling back the law (Vaida, 11/17).

Softer, more specific alternative to combat inflammation

Two types of guidance molecules, the attractive and the repulsive, direct the growth of nerve cells to the actual target. The designation of these molecules also describes the exclusive function that was previously attributed to them, namely to show the growing nerve fibers the way. The fundamentally new approach to the research of Prof. Dr. Schwab and his team at the Berlin-Brandenburg Center for Regenerative Therapies (BCRT) is the realization that these guidance molecules have an additional hitherto unknown role in the immune system.

AMRI's total revenue increases $89.5 million to 31% in second quarter 2015

AMRI today reported financial and operating results for the second quarter ended June 30, 2015. "We are very pleased to present another strong financial quarter, with all our divisions achieving excellent results," said William S. Marth, AMRI's president and chief executive officer. "Notably, recent acquisitions, combined with the cost reduction initiatives and efficiency efforts we've made to date, are contributing to continued strong contract margin performance.

Oncothyreon acquires Alpine Biosciences to enable targeted delivery of multiple therapeutic agents

Oncothyreon Inc., a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer, today announced that it has acquired Alpine Biosciences, Inc., of Seattle, Washington, a privately held biotechnology company developing protocells, a nanoparticle platform technology designed to enable the targeted delivery of multiple therapeutic agents, including nucleic acids, proteins, peptides and small molecules.

Otolaryngology Doctors in Islandia, NY

Dr. Robert M Gargano, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2929 Expressway Dr N, Islandia, NY 11749 Phone: 631-665-2430 Fax: 631-665-2342
Anna Stern, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2929 Expressway Dr N, Islandia, NY 11749 Phone: 631-665-2430 Fax: 631-665-2342
Ron D Gottlieb, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2929 Expressway Dr N, Islandia, NY 11749 Phone: 631-665-2430 Fax: 631-665-2342
Dr. George Andrew Poulos, D.O. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2929 Expressway Dr N, Islandia, NY 11749 Phone: 631-665-2430 Fax: 631-665-2342
Todd W. Campbell, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2929 Expressway Dr N, Islandia, NY 11749 Phone: 631-665-2430 Fax: 631-665-2342
Thomas R O'donnell, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2929 Expressway Dr N, Islandia, NY 11749 Phone: 631-665-2430 Fax: 631-665-2342

Edward J Lipinsky, MD - Otolaryngology in Islandia, NY